Actively Recruiting
Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch
Led by Erasmus Medical Center · Updated on 2025-08-13
175
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this single center prospective observational study is to determine the effect of chemotherapy on (the change in) vital parameters. The main question it aims to answer are: Can changes in vital parameters be measured by using a Fitbit in patients with cancer while undergoing chemotherapy. Participants will be asked to wear a Fitbit for the first two cycles of chemotherapy to evaluate the changes in vital parameters.
CONDITIONS
Official Title
Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age �38 years or older
- Diagnosis of stomach or esophageal cancer with planned chemotherapy
- Ability to use a Fitbit device
- Proficiency in Dutch language
- Able and willing to provide written informed consent
You will not qualify if you...
- Cognitive disorders or severe emotional instability
- Currently participating in an exercise trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Erasmus University Medical Center
Rotterdam, South Holland, Netherlands, 3015GD
Actively Recruiting
Research Team
J
Jason den Duijn, MSc.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here